WO2009058800A3 - Synthèse de nucléosides - Google Patents

Synthèse de nucléosides Download PDF

Info

Publication number
WO2009058800A3
WO2009058800A3 PCT/US2008/081499 US2008081499W WO2009058800A3 WO 2009058800 A3 WO2009058800 A3 WO 2009058800A3 US 2008081499 W US2008081499 W US 2008081499W WO 2009058800 A3 WO2009058800 A3 WO 2009058800A3
Authority
WO
WIPO (PCT)
Prior art keywords
synthesis
nucleosides
processes
nucleoside analogues
nucleoside
Prior art date
Application number
PCT/US2008/081499
Other languages
English (en)
Other versions
WO2009058800A2 (fr
Inventor
Gregory L Verdine
Seongmin Lee
Original Assignee
Harvard College
Gregory L Verdine
Seongmin Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Gregory L Verdine, Seongmin Lee filed Critical Harvard College
Publication of WO2009058800A2 publication Critical patent/WO2009058800A2/fr
Publication of WO2009058800A3 publication Critical patent/WO2009058800A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/067Pyrimidine radicals with ribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur un procédé de synthèse d'analogues de nucléosides.
PCT/US2008/081499 2007-10-29 2008-10-29 Synthèse de nucléosides WO2009058800A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98355007P 2007-10-29 2007-10-29
US60/983,550 2007-10-29

Publications (2)

Publication Number Publication Date
WO2009058800A2 WO2009058800A2 (fr) 2009-05-07
WO2009058800A3 true WO2009058800A3 (fr) 2009-07-16

Family

ID=40591723

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/081499 WO2009058800A2 (fr) 2007-10-29 2008-10-29 Synthèse de nucléosides

Country Status (1)

Country Link
WO (1) WO2009058800A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2861611T (pt) 2012-05-25 2016-10-11 Janssen Sciences Ireland Uc Nucleósidos de espirooxetano de uracilo
WO2014099941A1 (fr) 2012-12-19 2014-06-26 Idenix Pharmaceuticals, Inc. 4'-fluoro-nucléosides pour le traitement du vhc
BR112015014457A2 (pt) 2012-12-21 2017-11-21 Alios Biopharma Inc composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
CN105705511A (zh) 2013-04-12 2016-06-22 艾其林医药公司 用于治疗hcv的氘化核苷前药
BR112017013858A2 (pt) 2014-12-26 2018-02-27 Univ Emory n4-hidroxicitidina e derivados e usos antivirais relacionados aos mesmos
BR112020010581A2 (pt) 2017-12-07 2020-11-10 Emory University composição farmacêutica, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e de tratamento ou prevenção de coronavírus humano, sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus chikungunya e infecção por infecção de ross river, vírus orthomyxoviridae ou vírus paramyxoviridae ou vírus rsv, ou infecção pelo vírus influenza a e vírus influenza b ou vírus filoviridae ou vírus ebola.
KR20200140274A (ko) * 2018-03-07 2020-12-15 에모리 유니버시티 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도
CN113929724B (zh) * 2021-11-02 2024-05-31 周雨恬 一种核苷类化合物及其药物组合物和用途
CN114891048B (zh) * 2022-05-16 2024-03-26 浙江晟格生物科技有限公司 一种制备4-氟基-2,3,5-三-氧-苯甲酰基-β-L-呋喃核糖的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043691A1 (fr) * 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
US20050130274A1 (en) * 2001-09-05 2005-06-16 O'hagan David Enzymatic process for the synthesis of organo-fluorine compounds
WO2007053869A2 (fr) * 2005-11-09 2007-05-18 Saischek Und Partner Meg Dérives de furanose à substitution 2,2-dithio, procédé de production et leur utilisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043691A1 (fr) * 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
US20050130274A1 (en) * 2001-09-05 2005-06-16 O'hagan David Enzymatic process for the synthesis of organo-fluorine compounds
WO2007053869A2 (fr) * 2005-11-09 2007-05-18 Saischek Und Partner Meg Dérives de furanose à substitution 2,2-dithio, procédé de production et leur utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JUNG, M. E. ET AL.: "Preparation of 4'-substituted thymidines by substitution of the thymidine 5'-esters.", J. ORG. CHEM., vol. 66, 2001, pages 2624 - 2635 *

Also Published As

Publication number Publication date
WO2009058800A2 (fr) 2009-05-07

Similar Documents

Publication Publication Date Title
HRP20181774T1 (hr) Novi citostatski 7-deazapurinski nukleosidi
WO2009058800A3 (fr) Synthèse de nucléosides
ZA200804958B (en) Antiviral nucleosides
HK1138286A1 (en) Antiviral nucleoside analogs
ZA201003438B (en) Antiviral nucleoside compounds
WO2010036407A3 (fr) Analogues nucléosidiques antiviraux
EP2115469A4 (fr) Dosage enzymatique pour lspr
IL213701A0 (en) Synthesis of purine nucleosides
EP1964837A4 (fr) Agent antitumeur pour myelomes multiples
AU2008313789A8 (en) Purine derivatives as adenosine AL receptor ligands
EG25165A (en) Profile elements as carrier structure for the consstruction of walls.
HK1119660A1 (en) Separation of stereoisomeric n,n-dialkylamino-2-alkyl-3-phenyl alkanes
EP2194111A4 (fr) Système de réaction de synthèse
ZA200801708B (en) Synthesis of 1±-fluoro-25-hydroxy-16-23E-diene-26,27-bishomo-20-EPI-cholecalciferol
EP2205755A4 (fr) Système de production d'adénosine triphosphate
EP1844063A4 (fr) Analogues nucleosidiques puriques
GB2459413B (en) Methods for the synthesis of perfluoroparacyclophane
WO2007127309A3 (fr) Procede de synthese d'acide 3-isobutylglutarique
PL2137202T3 (pl) Sposób syntezy IB-MECA
GB0725382D0 (en) Typed application deployment
WO2009003001A3 (fr) Préparation d'hémi-pentahydrate de risédronate de sodium
IL200711A0 (en) Process for the synthesis of ib-meca
GB0509200D0 (en) Novel phosponate nucleosides
GB0511042D0 (en) Novel antiviral phosphonates nucleosides
GB0504649D0 (en) Novel antiviral phosphonates nucleosides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845071

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845071

Country of ref document: EP

Kind code of ref document: A2